Results 41 to 50 of about 3,191 (210)
Pharmacist-Driven Management of Chemotherapy Induced Nausea and Vomiting in Hospitalized Adult Oncology Patients. A Retrospective Comparative Study [PDF]
INNOVATIONS in Pharmacy, 2011 Chemotherapy-induced nausea and vomiting (CINV) is a major adverse event associated with cancer treatments. There are clinical practice guidelines that assist practitioners in managing CINV.
Ramy Elshaboury, PharmD +1 more
doaj +3 more sources
Tool zur CINV-Vorhersage [PDF]
Im Focus Onkologie, 2017 Trotz effektiver Antiemetika und evidenzbasierter Leitlinien leiden bis zu 40 % der Krebspatienten unter Chemotherapie nach wie vor unter Ubelkeit und Erbrechen. Ein neues Vorhersagemodell hilft, das Risiko besser abzuschatzen.
openaire +1 more source
Hyperglycemia from Glucocorticoid Use for Prophylaxis of Chemotherapy-induced Nausea and Vomiting (CINV) [PDF]
, 2021 Chemotherapy-induced nausea and vomiting (CINV), a frequent adverse effect of chemotherapy, is debilitating and negatively impacts patients’ wellbeing. Despite the introduction of newer antiemetics, glucocorticoids continue to play a fundamental role in ...
Bhimani, Sweta Pravinchandra
core +1 more source
IET Smart Energy Systems, EarlyView.An 8760‐hour optimisation model is developed for integrated wind–PV–CSP systems. Full‐factorial configuration and sensitivity analyses identify a clear optimal structure under grid and turbine constraints, enabling balanced trade‐offs among economic performance, peak‐period supply capability and energy utilisation and providing practical references for
Yang Hei +4 more
wiley +1 more source
Evaluation of daily breakthrough chemotherapy-induced nausea and vomiting (CINV) rates in a phase III study of NEPA versus an aprepitant (APR)/granisetron (GRAN) regimen. [PDF]
, 2017 120 Background: Antiemetic trials typically evaluate CINV control during acute (Day 1), delayed (Days 2-5), and overall (Days 1-5) phases post-chemotherapy; the daily course of events is often unstudied in the delayed phase.
Corinna Lanzarotti +4 more
core +1 more source
Revista Brasileira de Cancerologia, 2023 Introduction: Chemotherapy-induced nausea and vomiting (CINV) are common adverse drug reactions (ADR) experienced by children undergoing treatment for cancer.
Elisangela Costa Lima +8 more
doaj +1 more source
Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.ABSTRACT Background An international Delphi panel of experts developed consensus statements to delineate the circumstances where the risks of dexamethasone as an antiemetic do and do not outweigh its benefits. Procedure Experts in supportive care of pediatric patients were invited to participate.
Negar Shavandi +20 more
wiley +1 more source
Journal of Pharmaceutical Health Care and Sciences, 2023 Background Olanzapine treatment prevents chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC). However, its role in the secondary prevention of breakthrough CINV in real-world cancer care should be ...
Akihiro Uchiike +7 more
doaj +1 more source
Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman +8 more
wiley +1 more source
Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey [PDF]
, 2019 Introduction Preventing CINV is possible when guideline-recommended antiemetics are used. Because oncology nurses play a critical role in risk assessment and management of CINV, a survey of European nurses was conducted to evaluate antiemetic practices ...
Dielenseger, Pascale, +4 more
core +1 more source